Sofinnova Capital IX 13D and 13G filings for CinCor Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-03-03 10:06 am Sale |
2023-02-24 | 13D | CinCor Pharma, Inc. CINC |
Sofinnova Capital IX | 0 0.000% |
-4,220,979 (Position Closed) |
Filing |
| 2023-02-13 1:33 pm Purchase |
2023-02-10 | 13D | CinCor Pharma, Inc. CINC |
Sofinnova Capital IX | 4,220,979 9.600% |
4,220,979 (New Position) |
Filing |